Similar to models of glaucoma-relevant axonal injury [45] and ocular hypertension [46], deletion of Jun from RGCs prevented caspase 3 activation in RGCs and prevented later RGC loss after intravitreal EDN1 injection [44]. Here, CASP3 is linked to ocular hypertension.